RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:13 G filingIs it? I'm not sure it is based on the sources I used, but looking around this morning, I believe different sources are using specific funds, rather than the master fund. I think the combined reporting messed some of that up. SPCEO1 shows a slightly higher increase than I did by just more than 12K shares, but I'm seeing different share counts via different reports. The source I used yesterday appears to have been comparing apples to oranges...The Master Fund to Capital Management. I do want to get it right and track the correct details. What sources are you using?
If you use Fintel, which I think might be the best source going forward since it appears to match the combined total reporting of all the funds that roll up into the Master Fund per the 13G, share count increased by 433,827 shares. That doesn't match SPCEO1's number either. https://fintel.io/i/soleus-capital-master-fund-l-p
If you look at the THTX institutional holdings via Nasdaq, it appears to report only Soleus Capital Management and a 185,302 share increase. https://www.nasdaq.com/market-activity/stocks/thtx/institutional-holdings
I backed into the 6/30 13F filing for Soleus Capital Management initially, and the share count increase reported for them matches that. This makes it appear that there were other shares owned in addition to the 1,550,000 warrants in other funds that now when consolidated with the 13G result in an even higher share count. So now I'm confused as to if the reported 13G consolidated included shares already owned in other funds with the increase or if they truly bought the other 248,525 shares outside of Soleus Capital Management.
If you subtract the 1,550,000 warrants from the reported previously owned shares shown on Fintel in the link above, it's less than what Soleus Capital Management already owned on 6/30, so that doesn't make any sense.
What are you all using to calculate?
palinc2000 wrote:
Your math is wrong
PWIB123 wrote: If you subtract out the 1,550,000 shares represented by warrants, Soleus' ownership in various entities now owns a total 8,125,909 shares, plus the 1,550,000 warrants. As of 6/30, they reported 7,822,412 under Soleus Capital Management. The Master Fund owns the warrants, so they definitely increased shares over the last 5 months.
SPCEO1 wrote: While it is always hard to understand Soleus' filings because of how they treat the warrants, it appears they have added to their postion and that was the reason for their filing. It is separate from the 7.5 million share block trade which may be related to intercompany accoutning moves at Morgan Stanley? If so, that indicates they may ahve bought more shares too since they did not own 7.5 million shares as of 6/30.
qwerty22 wrote: "The shares of common stock reported in this row are held by Soleus Capital Master Fund, L.P. (“Master Fund”), and include a presently exercisable warrant to purchase up to 1,550,000 shares of common stock at an exercise price of $3.14 per share (the “Warrant”). Soleus Capital, LLC is the sole general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. "
So for people that don't understand these types of transactions, like me, why would Soleus do this?
palinc2000 wrote:
https://www.theratech.com/static-files/446de95b-5b8e-4464-9058-dd6bbd822fc7
SPCEO1 wrote: I cannot find that filing - where did you see it? Is it from today?
palinc2000 wrote:
My understsnfing is that the Filing is simply to account for the transfer of the shsres ftom Soleus to a General Partner controlled by Soleus
palinc2000 wrote: [The 9.5 mil'ion includes
1555000 warrabts
quote=palinc2000]
Seems like Soleus hold 9.5 million shares representing 10.1 %
palinc2000 wrote: Soleus
[/quote]